Medicinal Organic Cannabis Australia (MOCA) is ready to move into importing a range of products under thier own brand and starting to manufacture cannabis medical products for wholesale to the healthcare industry.
The Company has submitted applications to the New Zealand Government in December 2018, for licences to import cannabis products and to establish a facility to cultivate medical marijuana.
MOCA has ambitious plans for expansion in Australia, New Zealand and internationally and has a number of business projects which will see the company Importing organic medicinal products under our own brand. As a first mover, MOCA’s expansion into import/export and cultivation opportunities in New Zealand make for a great investment. Soon the company will be supplying organic MOCA branded medications to an international market.
The international market and its opportunities
The combined cannabis industry globally is anticipated to reach over US$500 billion when it is fully developed, recent reports indicate that the market is currently valued at US$10 million so we are still in the infancy stage (2% of total market). Ground floor opportunities with innovative companies who have a multifaceted approved to the market are currently seeking investments to grow and capitalize on the cannabis markets growth.
Several countries have taken the significant step of moving from legalising medical cannabis to introducing recreational cannabis. The first country to legalise was Uruguay, where MOCA’s partner company OrganicMarijuana.com has substantial holdings.
Canadian Prime Minister Justin Trudeau was the next to legalise cannabis in Canada for recreational purposes and the market has expanded exponentially with huge growth. Over the past years many of the states in the America have legalised cannabis for medical and also for recreational purposes and we have seen California become one of the biggest markets in the world. Part to the reason for the shift in position from the government’s perspective is the very significant opportunities for raising taxes and revenue from the cannabis crop. Of course there is also growing evidence that the use of cannabis also reduces dependency on opioids. This is very important because the cost savings to health care systems is substantial.